Tag : Pfizer

Clinical Research, Pharma & Healthcare Financing

FDA Grants Full Approval to Pfizer’s BRAFTOVI for Metastatic Colorectal Cancer

Business Wire
by Business Wire071
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination with cetuximab (marketed...
Clinical Research, Pharma & Healthcare Financing

Pfizer Launches TrumpRx Program to Cut Drug Costs

Business Wire
by Business Wire063
Pfizer Inc. (NYSE: PFE) today announced the launch of its program on TrumpRx, making innovative medicines more affordable and accessible to millions of Americans. Starting today,...